The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Share News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

REPEAT: LONDON MARKET MIDDAY: PMIs, Gazprom send European stocks lower

Mon, 05th Sep 2022 12:35

(Correcting that New York is closed for holiday on Monday.)

(Alliance News) - Stock markets were being sold off on Monday, after Russia cut off gas supply via a key pipeline and a series of private sector surveys confirmed the damage being done to the European economy.

On Friday, Gazprom said that a gas pipeline to Germany - which was due to reopen at the weekend - would remain shut until a turbine is repaired, cutting off indefinitely an energy supply route to Europe.

"Predictably, wholesale gas prices are soaring, raising the prospect of even higher energy bills for businesses and consumers and sending the pound and the euro to new multi-year lows against the dollar," AJ Bell investment director Russ Mould said.

The euro traded at USD0.9936 midday Monday, down from USD1.0027 late Friday. Sterling was priced at USD1.1510, down from USD1.1575.

The UK will learn Monday who will be its next prime minister, with Liz Truss the favourite to succeed Boris Johnson and take charge as the country battles a spiralling cost-of-living crisis. The result will be announced at 1230 BST, after foreign minister Truss and her rival, former finance minister Rishi Sunak, spent the summer rallying support among the Conservative Party members who cast the final vote.

If she wins, Truss will become the UK's third female prime minister following Theresa May and Margaret Thatcher. The 47-year-old has consistently been ahead of 42-year-old Sunak in polling among the estimated 200,000 Tory members eligible to vote.

The FTSE 100 index was down 51.56 points, or 0.7%, at 7,229.63 midday Monday. The mid-cap FTSE 250 index was down 219.21 points, or 1.2%, at 18,634.01. The AIM All-Share index was down 5.08 points, or 0.6%, at 861.11.

The Cboe UK 100 index was down 0.7% at 722.49. The Cboe 250 was down 1.1% at 15,981.03, and the Cboe Small Companies down 0.3% at 13,682.72.

In mainland Europe, the CAC 40 in Paris was down 1.7%, while the DAX 40 in Frankfurt was 2.4% lower.

"Bullish market drivers are becoming increasingly difficult to find for stock traders, especially in Europe where the energy crisis ramped up again following Gazprom's decision to halt gas deliveries to the EU through one of its key pipelines, as a retaliation measure against the oil purchase price cap set up by leaders of the G7 nations," Pierre Veyret, technical analyst at ActivTrades, said.

"This decision added pressure to an already uncertain macro context and will likely continue to drive [equities] prices down in the short-term."

Brent oil was trading at USD95.51 a barrel, higher than USD94.00 late Friday.

Oil also was being bid up as the OPEC+ countries are expected to agree a modest increase in oil production at a meeting on Monday,

The 13 members of the Organization of the Petroleum Exporting Countries cartel, led by Saudi Arabia, and their 10 partners, led by Russia, are meeting to adjust their quotas for October. Talks were scheduled to start at 1200 BST.

Adding to the downbeat mood was a report showing the eurozone's private sector fell into decline in August, as a drop in demand and cost-of-living concerns led to weakness in business activity.

The S&P Global eurozone services purchasing managers' index swung down to 49.8 points from 51.2 points in July, passing below the neutral mark of 50.0 points to indicate a contraction. The reading for August marked a 17-month low.

As well, the UK services sector's growth slowed in August, as sales took a hit from growing economic uncertainty and reduced client confidence.

The headline seasonally adjusted S&P Global/Chartered Institute of Procurement UK services PMI business activity index fell to 50.9 points in August from 52.6 in July.

Despite being in growth territory, the print came in well short of market expectations, according to FXStreet, of 52.5.

S&P Global noted August's reading was the softest in 18 months.

In London, miners were in the green. Glencore was up 4.1%, Antofagasta 2.0%, Anglo American 1.1% and Rio Tinto was 1.0% higher.

Anchored to the bottom of the FTSE 100 was Dechra Pharmaceuticals, down 9.0%.

The veterinary products firm reported higher full-year profit and revenue, though it warned that growth rates are normalising as pandemic tailwinds ease.

In the financial year that ended June 30, Dechra reported revenue of GBP681.8 million, up 12% from GBP608.0 million the year before. Pretax profit increased 4.9% to GBP77.6 million, compared to GBP74.0 million in 2021.

With financial year 2022 revenue and profit rising, Dechra lifted its annual payout by 11% to 44.89p from 40.50p a year earlier.

However, Dechra noted that revenue in the second half of the year normalised to historic levels of growth, as the benefit of increased spending on pets seen during the Covid-19 restrictions slowed down.

Among London midcaps, Countryside Partnerships was the best performer, advancing 5.5%.

The housebuilder agreed to be acquired by peer Vistry Group.

The cash-and-shares deal, worth about GBP1.25 billion, values Countryside shares at 249 pence each, a 9.1% premium to its closing price on Friday.

Vistry is offering 0.255 of a share and 60 pence cash for each Countryside share. The merger is expected to close in the first quarter of 2023.

Vistry added it expects the combination to be return-on-capital-employed enhancing from 2024.

Countryside shareholders will own about 37% of enlarged firm. "The combination would create one of the country's leading homebuilders, comprising a top tier housebuilder and a leading partnerships business, with capability across all housing tenures, and delivering much needed affordable housing," Vistry explained.

Vistry expects the combined revenue to increase to over GBP3 billion per year, much higher than its medium term target of around GBP1.6 billion.

Vistry was 0.3% higher.

Heading in the opposite direction, sports car maker Aston Martin shed 9.9%.

It confirmed its plan for the launch of a rights issue to raise GBP575.8 million, supported by a fund controlled by Saudi Arabia's de facto leader.

Aston Martin noted Saudi Arabia's sovereign wealth fund, the Public Investment Fund, Lawrence Stroll's Yew Tree Consortium, and fellow car maker Mercedes-Benz are taking up their full entitlements, amounting to 45% of the total rights issue.

Aston will issue 559 million new shares as part of its rights issue, on the basis of four new shares for every one existing share. The shares will be issued at a price of 103 pence each, reflecting a 79% discount to the company's closing price on Friday last week at 480p.It was trading at 437.46p around midday on Monday.

Wall Street is closed on Monday for the Labor Day holiday.

Against the yen, the dollar was quoted at JPY140.48, up from JPY140.05.

Gold was quoted at USD1,714.10 an ounce early Monday, up from USD1,713.90 on late Friday.

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
23 Feb 2022 09:37

LONDON BROKER RATINGS: SocGen cuts Kingfisher; Liberum raises Dechra

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
23 Feb 2022 07:59

Liberum upgrades Dechra after share price weakness

(Sharecast News) - Liberum upgraded Dechra Pharmaceuticals to 'hold' from 'sell' and lifted the price target to 4,020p from 4,000p on Wednesday following weakness in the share price.

Read more
23 Feb 2022 07:59

Liberum upgrades Dechra after share price weakness

(Sharecast News) - Liberum upgraded Dechra Pharmaceuticals to 'hold' from 'sell' and lifted the price target to 4,020p from 4,000p on Wednesday following weakness in the share price.

Read more
22 Feb 2022 19:07

easyJet could return to FTSE 100 next month, Dechra may be bumped

(Alliance News) - FTSE Russell late Tuesday indicated that, ahead of next week's quarterly UK index review, airline easyJet PLC could once again fly into the FTSE 100 index, with veterinary products company Dechra Pharmaceuticals PLC bumped out in the process.

Read more
22 Feb 2022 09:56

LONDON BROKER RATINGS: Jefferies downgrades three utility stocks

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
21 Feb 2022 12:14

LONDON MARKET MIDDAY: Stocks down as Russia pours cold water on summit

(Alliance News) - Stock prices in London turned lower at midday on Monday after conflicting statements about plans for a US-Russia summit to discuss Ukraine, dousing an earlier wave of optimism.

Read more
21 Feb 2022 09:11

TOP NEWS: Dechra Pharmaceuticals profit grows on more spending on pets

(Alliance News) - Dechra Pharmaceuticals PLC on Monday reported higher half-year profit and revenue amid increased consumer spending on pets.

Read more
21 Feb 2022 08:58

LONDON MARKET OPEN: Stocks rise on hope of US-Russia summit on Ukraine

(Alliance News) - Stock prices in London opened higher on Monday on hopes of a summit about Ukraine between US President Joe Biden and Russian President Vladimir Putin.

Read more
21 Feb 2022 08:04

Dechra Pharmaceuticals lifts interim dividend as profits rise

(Sharecast News) - Dechra Pharmaceuticals lifted its interim dividend on Monday as it posted a jump in profit and revenue.

Read more
21 Feb 2022 07:48

LONDON MARKET PRE-OPEN: Dechra raises dividend after strong results

(Alliance News) - Stock prices in London are seen opening higher on Monday on the possibility of a summit about Ukraine between US President Joe Biden and his Russian counterpart Vladimir Putin.

Read more
14 Feb 2022 16:43

UK earnings, trading statements calendar - next 7 days

<table style="width: 392px;" border="0" cellspacing="0" cellpadding="0"><colgroup><col width="271" /> <col width="121" /> </colgroup><tbody><tr><td class="xl68" width="271" height="21"><strong>Tuesday 15 February</strong></td><td class="xl67" width="121">&nbsp;</td></tr><tr><td class="xl67" height="21">BHP Group Ltd</td><td class="xl67">Half Year Results</td></tr><tr><td class="xl67" height="21">Glencore PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">Plus500 Ltd</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">RM PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl69" height="21"><strong>Wednesday 16 February</strong></td><td class="xl67">&nbsp;</td></tr><tr><td class="xl67" height="21">Coca-Cola Europacific Partners PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">Indivior PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">Ocean Outdoor Ltd</td><td class="xl67">Trading Statement</td></tr><tr><td class="xl67" height="21">Pan African Resources PLC</td><td class="xl67">Half Year Results</td></tr><tr><td class="xl67" height="21">Primary Health Properties PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl68" height="21"><strong>Thursday 17 February</strong></td><td class="xl67">&nbsp;</td></tr><tr><td class="xl67" height="21">Aveva Group PLC</td><td class="xl67">Trading Statement</td></tr><tr><td class="xl67" height="21">MoneySupermarket.com PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">Reckitt Benckiser Group PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">Safestore Holdings PLC</td><td class="xl67">Trading Statement</td></tr><tr><td class="xl67" height="21">South32 Ltd</td><td class="xl67">Half Year Results</td></tr><tr><td class="xl67" height="21">Standard Chartered PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">Yamana Gold Inc</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl68" height="21"><strong>Friday 18 February&nbsp;</strong></td><td class="xl67">&nbsp;</td></tr><tr><td class="xl67" height="21">NatWest Group PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">Pod Point Group Holdings PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">Segro PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">TBC Bank Group PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21"><strong>Monday 21 February</strong></td><td class="xl67">&nbsp;</td></tr><tr><td class="xl67" height="21">Bank of Cyprus Holdings PLC</td><td class="xl67">Full Year Results</td></tr><tr><td class="xl67" height="21">Dechra Pharmaceuticals PLC</td><td class="xl67">Half Year Results</td></tr><tr><td class="xl67" height="21">Finsbury Food Group PLC</td><td class="xl67">Half Year Results</td></tr><tr><td class="xl67" height="21">Sylvania Platinum Ltd</td><td class="xl67">Half Year Results</td></tr><tr><td class="xl67" height="21">Tristel PLC</td><td class="xl67">Trading Statement</td></tr><tr><td class="xl67" height="21">Wilmington PLC</td><td class="xl67">Half Year Results</td></tr><tr><td class="xl67" height="21">&nbsp;</td><td class="xl67">&nbsp;</td></tr><tr><td class="xl70" colspan="2" height="21">Copyright 2022 Alliance News Limited. All Rights Reserved.</td></tr></tbody></table>

Read more
13 Jan 2022 09:39

TOP NEWS: Dechra to post interim revenue growth, keeps annual outlook

TOP NEWS: Dechra to post interim revenue growth, keeps annual outlook

Read more
13 Jan 2022 09:11

LONDON MARKET OPEN: Countryside down as CEO departs; ASOS to leave AIM

LONDON MARKET OPEN: Countryside down as CEO departs; ASOS to leave AIM

Read more
13 Jan 2022 08:09

Dechra sees full year at upper end of management expectations

(Sharecast News) - Dechra Pharmaceuticals said on Thursday that the full-year outlook was towards the upper end of management expectations as it reported a jump in first-half revenues.

Read more
11 Jan 2022 23:42

Dechra acquires worldwide rights to canine lymphoma treatment

(Sharecast News) - Pharmaceutical giant Dechra has acquired the worldwide rights to verdinexor, a novel treatment of all forms and stages of canine lymphoma from Anivive Lifesciences.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.